- Home
- ASO vs ICUI Comparison
ASO vs ICUI Comparison
Compare ASO & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASO
- ICUI
- Stock Information
- Founded
- ASO 1938
- ICUI 1984
- Country
- ASO United States
- ICUI United States
- Employees
- ASO N/A
- ICUI N/A
- Industry
- ASO Recreational Games/Products/Toys
- ICUI Medical/Dental Instruments
- Sector
- ASO Consumer Discretionary
- ICUI Health Care
- Exchange
- ASO Nasdaq
- ICUI Nasdaq
- Market Cap
- ASO 4.0B
- ICUI 4.0B
- IPO Year
- ASO 2020
- ICUI 1992
- Fundamental
- Price
- ASO $53.58
- ICUI $162.32
- Analyst Decision
- ASO Buy
- ICUI Buy
- Analyst Count
- ASO 16
- ICUI 4
- Target Price
- ASO $66.47
- ICUI $138.33
- AVG Volume (30 Days)
- ASO 1.2M
- ICUI 257.7K
- Earning Date
- ASO 09-10-2024
- ICUI 08-07-2024
- Dividend Yield
- ASO 0.82%
- ICUI N/A
- EPS Growth
- ASO N/A
- ICUI N/A
- EPS
- ASO 6.54
- ICUI N/A
- Revenue
- ASO $6,139,902,000.00
- ICUI $2,304,277,000.00
- Revenue This Year
- ASO $0.63
- ICUI $3.80
- Revenue Next Year
- ASO $6.36
- ICUI $4.01
- P/E Ratio
- ASO $8.19
- ICUI N/A
- Revenue Growth
- ASO N/A
- ICUI 0.46
- 52 Week Low
- ASO $42.83
- ICUI $78.28
- 52 Week High
- ASO $75.73
- ICUI $166.46
- Technical
- Relative Strength Index (RSI)
- ASO 48.95
- ICUI 66.44
- Support Level
- ASO $52.95
- ICUI $159.10
- Resistance Level
- ASO $55.82
- ICUI $166.46
- Average True Range (ATR)
- ASO 1.29
- ICUI 3.76
- MACD
- ASO -0.10
- ICUI -0.98
- Stochastic Oscillator
- ASO 18.31
- ICUI 66.72
About ASO Academy Sports and Outdoors Inc.
Academy Sports and Outdoors Inc is engaged in the retail business of sporting goods and outdoor recreation products. The product categories of the company are outdoors, apparel, sports & recreation, and footwear.
About ICUI ICU Medical Inc.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.